This dual receptor action can affect appetite, insulin sensitivity, blood sugar, and body weight
This could relate to different pharmacokinetic profiles, lower peak drug levels, or differences in how the oral versus injectable forms interact with the nervous system
Doses of 100 to 200 mg daily are typical
Patients should be monitored for any exacerbation of gastrointestinal symptoms when using both medications concurrently
Never leave semaglutide in a hot car, direct sunlight, or near heat sources like stoves or radiators
Furthermore, extending the post-dose fasting period from 10 or 15 min up to 30 min increased the absorption of both oral salmon calcitonin (by approximately 30%) and ibandronate co-formulated with SNAC (by approximately twofold) [13, 14]